section name header

Pronunciation ⬇

eff-in-a-KON-a-zole

Classifications ⬆ ⬇

Therapeutic Classification: antifungals

Pharmacologic Classification: triazoles

Indications ⬆ ⬇

REMS


Action ⬆ ⬇

  • Inhibits synthesis of ergosterol, a component of fungal cell membranes.
Therapeutic effects:
  • Resolution of toenail fungus.

Spectrum:

Pharmacokinetics ⬆ ⬇

Absorption: Minimal systemic absorption follows application to toenails.

Distribution: Unknown.

Metabolism/Excretion: Unknown.

Half-Life: 29.9 hr.

Time/Action Profile ⬆ ⬇

ROUTEONSETPEAKDURATION
Topical‡unknownunknownunknown

‡Prolonged treatment is necessary due to need for treatment throughout growth of new toenails.



Contraind./Precautions ⬆ ⬇

Contraindicated in:

Use Cautiously in:

Adv. Reactions/Side Effects ⬆ ⬇

Local: application site dermatitis, application site pain, application site vesicles, ingrown toenail

Interactions ⬆ ⬇

Drug-drug:

Route/Dosage ⬆ ⬇

Availability ⬆ ⬇

(Generic available)

Assessment ⬆ ⬇

Implementation ⬆ ⬇

Patient/Family Teaching ⬆ ⬇

Evaluation/Desired Outcomes ⬆ ⬇

US Brand Names ⬆

Jublia